Cosmo Pharmaceuticals recently released promising new data for a major hair loss treatment. Their topical solution uses clascoterone at a 5% concentration. This drug targets male pattern baldness in a brand-new way. It works by blocking androgen receptors directly in the hair follicles. The treatment stops dihydrotestosterone from shrinking hair growth cycles. Unlike oral pills, this topical liquid does not ...